Related Experiment Video
Updated: Dec 24, 2025

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
Published on: April 21, 2023
Silver nanoparticle-ionic silsesquioxane: a new system proposed as an antibacterial agent
Andressa C Schneid1, Eliane W Roesch, Fernanda Sperb
1Instituto de Química, Universidade Federal do Rio Grande do Sul (UFRGS), CP 15003, CEP 91501-970, Porto Alegre, RS, Brazil.
Researchers developed stable, positively charged silver nanoparticles using a novel silsesquioxane stabilizer. These nanoparticles exhibit potent antibacterial activity against E. coli, P. aeruginosa, and S. aureus, with low cytotoxicity to mammalian cells.
Area of Science:
- Nanotechnology
- Materials Science
- Microbiology
Background:
- Silver nanoparticles (AgNPs) are recognized for their antimicrobial properties.
- Developing stable and effective AgNPs requires precise control over size and surface charge.
- Existing AgNP formulations often face challenges with stability and require higher concentrations for efficacy.
Purpose of the Study:
- To synthesize and characterize novel spherical silver nanoparticles (AgNPs) using a charged silsesquioxane stabilizer.
- To evaluate the antibacterial efficacy of the synthesized AgNPs against common bacterial pathogens.
- To assess the stability and cytotoxicity of the AgNPs for potential therapeutic applications.
Main Methods:
- Synthesis of ~5 nm spherical AgNPs in aqueous medium utilizing a quaternary ammonium-containing silsesquioxane as a stabilizer and size controller.
- Characterization of AgNP stability using UV-Vis spectroscopy over one year and zeta potential measurements.
- In vitro antibacterial assays against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus.
- Cytotoxicity assessment on mammalian cells.
Main Results:
- Successfully synthesized stable, positively charged (~5 nm) spherical AgNPs with a zeta potential of +24.7 mV.
- Demonstrated high stability of AgNPs, evidenced by unchanged UV-Vis spectra after one year.
- Achieved potent in vitro antibacterial activity with low minimum inhibitory concentrations (MICs): 0.60 μg mL⁻¹ for E. coli, 1.1 μg mL⁻¹ for P. aeruginosa, and 2.0 μg mL⁻¹ for S. aureus.
- Confirmed safety of AgNPs for mammalian cells at effective antibacterial concentrations.
Conclusions:
- The novel silsesquioxane-stabilized AgNPs represent a highly stable and effective antibacterial agent.
- The low MIC values and excellent safety profile make these AgNPs promising for various antimicrobial applications.
- This study introduces a new, efficient method for AgNP synthesis with significant potential in combating bacterial infections.
More Related Videos
05:57Author Spotlight: Metallic Nanocomposites to Eliminate Antibiotic-Resistant Bacteria
Published on: October 4, 2024
11:19Synthesis of Multi-walled Carbon Nanotubes Modified with Silver Nanoparticles and Evaluation of Their Antibacterial Activities and Cytotoxic Properties
Published on: May 10, 2018